Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Delnova, Pace Life Sciences Partner on ReViVox Development | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Delnova, Pace Life Sciences Partner on ReViVox Development

Will support clinical development of DelNova’s lead candidate ReViVox to reverse unwanted paralysis induced by BoNTs such as Botox.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

DelNova has entered a partnership with Pace Life Sciences to serve as its contract development and manufacturing organization. The partnership will support clinical development of DelNova’s lead candidate ReViVox for the rescue of undesirable outcomes which may arise from a botulinum neurotoxin (BoNT) treatment such as Botox. Pace Life Sciences provides a full suite of contract CMC development, clinical trials materials manufacturing, and regulatory compliance, services to the biopharmaceutical industries.
 
Pace Life Sciences offers the support needed to complete the IND (investigational new drug)- enabling research for the future FDA submissions including formulation, kinetics, and stability.
 
Also, through its partnership with Pace Life Sciences, DelNova will now have the capacity to manufacture small GMP batches of drug product for clinical studies. Pace has facilities across the U.S., including a specialized CDMO facility in San Diego with expertise in complex drug delivery, formulation, sterile fill-finish GMP manufacturing.
 
Currently there is no product available that can reverse unwanted paralysis induced by BoNTs. ReViVox has the potential to be the first in class product to address this unmet medical need.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics